Edition:
India

ASKA Pharmaceutical Co Ltd (4514.T)

4514.T on Tokyo Stock Exchange

1,332JPY
22 Jun 2018
Change (% chg)

¥97 (+7.85%)
Prev Close
¥1,235
Open
¥1,398
Day's High
¥1,398
Day's Low
¥1,296
Volume
853,000
Avg. Vol
140,273
52-wk High
¥2,264
52-wk Low
¥1,222

Latest Key Developments (Source: Significant Developments)

Takeda Pharmaceutical and ASKA Pharmaceutical enter into licensing agreement for relugolix in women's health indications
Thursday, 31 May 2018 

May 31 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>:Says it and ASKA Pharmaceutical Co Ltd <<<4514.T>>> announced today that they entered inter a licensing agreement to grant ASKA exclusive commercialization right for uterine fibroids and exclusive development and commercialization rights for endometriosis for Japan to maximize the product value of Takeda-owned relugolix.Based on this agreement, Takeda will receive upfront payment for granting the exclusive commercialization right for uterine fibroids and the exclusive development and commercialization rights for endometriosis in Japan as well as holding the right to receive royalties on sales.  Full Article

ASKA Pharmaceutical to set up pharmaceutical JV in India
Monday, 16 Apr 2018 

April 16 (Reuters) - ASKA Pharmaceutical Co Ltd <4514.T>:Says it will set up a pharmaceutical JV with Omnicare Drugs India Private Limited, in India, in May .Says the JV will be capitalized at $12.5 million .Says it will hold 30 percent stake in the JV .  Full Article

BRIEF-ASKA Pharmaceutical to set up pharmaceutical JV in India

* Says it will set up a pharmaceutical JV with Omnicare Drugs India Private Limited, in India, in May